MAPT and Alzheimer disease: The ATN biological diagnostic framework underpins the importance of Aβ and p‐tau as the core characteristics of AD, hence promoting that AD can be diagnosed via biomarkers only, and even explicitly distinguishing it from other dementias, and as well could potentially be used in a precision medicine‐oriented method to give suitable treatments paradigm.10, 11